Dr. Xu Ji Highlights the Importance of Medicaid Coverage for Pediatric Lymphoma Care

7 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
Blood Cancers Today spoke with Xu Ji, PhD, MSPH, of Emory University School of Medicine, an expert on health care system access and policy issues faced by pediatric patients with cancer and their families.

As explained by Dr. Ji, Medicaid coverage is extremely important for timely diagnosis of lymphoma and access to care. In this interview she describes her database study, published in Blood Advances, which assessed what proportion of pediatric, adolescent, and young adult patients with lymphoma possessed Medicaid coverage before receiving the diagnosis versus the proportion enrolled only at the time of diagnosis.

Dr. Ji found that only three of eight patients with lymphoma had Medicaid coverage in the 12 months before receiving the diagnosis. Other patterns she identified were that patients who were only enrolled at or shortly after diagnosis were more likely to present with stage IV disease and that adolescent and young adult patients were less likely to be enrolled in Medicaid than pediatric patients.

“Our findings really highlight the importance of multilevel policies or interventions and to improve the continuity of Medicaid coverage for low-income patients with cancer,” Dr. Ji remarked.

----------
Blood Cancers Today is a new publication that provides hematologists and oncologists with news, education, and information relevant to their patients and practices, with insight from experts in the field. As the online home of the publication, bloodcancerstoday.com is updated daily, with the most current information from around the specialty and multimedia content, including exclusive interviews with presenters at major medical meetings.

Blood Cancers Today was developed to reach all professionals in the hematology/oncology universe, covering the latest news and analysis in leukemia, lymphoma, myeloma, myeloproliferative neoplasms, and other hematologic malignancies.
Category
Oncology
Be the first to comment

Up Next